Ryan Zarychanski

Also affiliated with Collaborative Group (United States), Research Institute in Oncology and Hematology, University of Manitoba

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial”.

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1571

N/A

4.6DataRank · unranked

128 citations

Ananta Bangdiwala, Melanie R. Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L. Axelrod +30 more

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa500

N/A

2.2DataRank · unranked

52 citations

Melanie R. Nicol, Ananta Bangdiwala, Katelyn A Pastick, Elizabeth C Okafor, Caleb P Skipper +22 more

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

medRxiv(2020)10.1101/2020.07.16.20155531

N/A

0.449DataRank · unranked

19 citations

Melanie R. Nicol, Ananta Bangdiwala, Katelyn A Pastick, Elizabeth C Okafor, Caleb P Skipper +22 more

Transfusion in orthopaedic surgery

Bone & Joint Open(2021)10.1302/2633-1462.210.bjo-2021-0077.r1

N/A

0.406DataRank · unranked

14 citations

Brett L. Houston, Dean A. Fergusson, Donald S. Houston, Emily Rimmer, Éric Bohm +7 more

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

JACC Advances(2024)10.1016/j.jacadv.2023.100780

N/A

0.292DataRank · unranked

6 citations

Matthew D. Neal, Ewan C. Goligher, Mary Cushman, Brett L. Houston, Charlotte Bradbury +35 more

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial

CHEST Journal(2023)10.1016/j.chest.2023.11.019

N/A

0.216DataRank · unranked

3 citations

Kinsley Hubel, Joshua Froess, Stephen R. Wisniewski, Vidya Venugopal, Yu‐Hsuan Lai +23 more

Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102203

N/A

0.129DataRank · unranked

1 citations

Anna Heath, Matthew D. Neal, Ryan Zarychanski, Lucy Z. Kornblith, Beverley J. Hunt +5 more

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14428

N/A

0DataRank · unranked

17 citations

Matthew D. Neal, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman +72 more

A comparison of computational algorithms for the Bayesian analysis of clinical trials

Clinical Trials(2024)10.1177/17407745241247334

N/A

0DataRank · unranked

8 citations

Jeffrey S. Berger, Lana A. Castellucci, Michael E. Farkouh, Ewan C. Goligher, Erinn M. Hade +9 more

ISTH guidelines for antithrombotic treatment in COVID‐19

Journal of Thrombosis and Haemostasis(2022)10.1111/jth.15808

N/A

0DataRank · unranked

181 citations

Michelle Sholzberg, Alex C. Spyropoulos, Ryan Zarychanski, Helaine E. Resnick, Charlotte Bradbury +13 more

Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial

Thrombosis and Haemostasis(2024)10.1055/s-0044-1786030

N/A

0DataRank · unranked

0 citations

Joshua D. Froess, Patrick R. Lawler, Mathew D. Neal, Ryan Zarychanski, Robert S. Rosenson +2 more

On-Treatment Change in d -Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19

Arteriosclerosis Thrombosis and Vascular Biology(2024)10.1161/atvbaha.124.321108

N/A

0DataRank · unranked

0 citations

Joshua Froess, Thomas L. Ortel, Ryan Zarychanski, Jeffrey S. Berger, Mary Cushman +11 more

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102167

N/A

0DataRank · unranked

8 citations

Erinn M. Hade, Lucy Z. Kornblith, Lana A. Castellucci, Mary Cushman, Michael E. Farkouh +16 more

Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00054-2

N/A

0DataRank · unranked

35 citations

Alexandra B. Spicer, Andrea Castellví-Font, Ann A. Zalucky, José Dianti, Emma Graham Linck +51 more